The dietary flavonol quercetin ameliorates angiotensin II-induced redox signalling imbalance in a human umbilical vein endothelial cell model of endothelial dysfunction via ablation of p47(phox) expression

Molecular Nutrition & Food Research
Huw S JonesFraser L Courts

Abstract

Quercetin is reported to reduce blood pressure in hypertensive but not normotensive humans, but the role of endothelial redox signalling in this phenomenon has not been assessed. This study investigated the effects of physiologically-obtainable quercetin concentrations in a human primary cell model of endothelial dysfunction in order to elucidate the mechanism of action of its antihypertensive effects. Angiotensin II (100 nM, 8 h) induced dysfunction, characterised by suppressed nitric oxide availability (85 ± 4% p<0.05) and increased superoxide production (136 ± 5 %, p<0.001). These effects were ablated by an NADPH oxidase inhibitor. Quercetin (3 μM, 8 h) prevented angiotensin II induced changes in nitric oxide and superoxide levels, but no effect on upon nitric oxide or superoxide in control cells. The NADPH oxidase subunit p47(phox) was increased at the mRNA and protein levels in angiotensin II-treated cells (130 ± 14% of control, p<0.05), which was ablated by quercetin co-treatment. Protein kinase C activity was increased after angiotensin II treatment (136 ± 51%), however this was unaffected by quercetin co-treatment. Physiologically-obtainable quercetin concentrations are capable of ameliorating angiotensin II-induced end...Continue Reading

References

Oct 4, 2005·Journal of the American College of Cardiology·Christian HeissMalte Kelm
Feb 22, 2007·Journal of Cardiovascular Pharmacology·Christian HeissHelmut Sies
Jun 15, 2007·Biochemical and Biophysical Research Communications·Yvonne SteffenHelmut Sies
Oct 24, 2007·The Journal of Nutrition·Randi L EdwardsThunder Jalili
Nov 6, 2007·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Yeon Jeong ChaeAgapios Sachinidis
Nov 13, 2007·Archives of Biochemistry and Biophysics·Yvonne SteffenHelmut Sies
Apr 22, 2008·The Journal of Nutrition·Wieslaw WiczkowskiMariusz K Piskula
Jul 11, 2008·The American Journal of Clinical Nutrition·Lee HooperAedín Cassidy
May 20, 2009·The British Journal of Nutrition·Alberto DávalosMiguel A Lasunción
Sep 3, 2009·Journal of Agricultural and Food Chemistry·Maaike M AppeldoornPeter C H Hollman
Apr 29, 2010·Free Radical Biology & Medicine·Nicholas K H KhooDale A Parks
Dec 18, 2010·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Hee Yul AhnTae-Sun Ha
Feb 18, 2011·British Journal of Pharmacology·K WinglerH H H W Schmidt
Nov 29, 2011·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·M PfeufferJ Schrezenmeir
Feb 15, 2012·Advances in Nutrition·Abigail J LarsonThunder Jalili
Mar 16, 2012·Endocrine Reviews·Laura N VandenbergJohn Peterson Myers
Jul 30, 2014·Trends in Endocrinology and Metabolism : TEM·Grant R Drummond, Christopher G Sobey
Jan 19, 2010·Pharmaceuticals·Abigail J LarsonThunder Jalili

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.